KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Debt Ratio (2016 - 2017)

Arbutus Biopharma's Debt Ratio history spans 2 years, with the latest figure at 0.05 for Q4 2017.

  • On a quarterly basis, Debt Ratio rose 16.34% to 0.05 in Q4 2017 year-over-year; TTM through Dec 2017 was 0.05, a 16.34% increase, with the full-year FY2017 number at 0.05, up 16.34% from a year prior.
  • Debt Ratio hit 0.05 in Q4 2017 for Arbutus Biopharma, up from 0.05 in the prior quarter.
  • Over the last five years, Debt Ratio for ABUS hit a ceiling of 0.05 in Q4 2017 and a floor of 0.04 in Q4 2016.